Cargando…
Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes
Mitochondria generate energy but malfunction in many cancer cells, hence targeting mitochondrial metabolism is a promising approach for cancer therapy. Here we have designed cyclometallated iridium(iii) complexes, containing one TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl) spin label [C(43)H(43)N(6)...
Autores principales: | Venkatesh, V., Berrocal-Martin, Raul, Wedge, Christopher J., Romero-Canelón, Isolda, Sanchez-Cano, Carlos, Song, Ji-Inn, Coverdale, James P. C., Zhang, Pingyu, Clarkson, Guy J., Habtemariam, Abraha, Magennis, Steven W., Deeth, Robert J., Sadler, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857930/ https://www.ncbi.nlm.nih.gov/pubmed/29568475 http://dx.doi.org/10.1039/c7sc03216a |
Ejemplares similares
-
Potent Half-Sandwich Iridium(III) Anticancer Complexes
Containing C(∧)N-Chelated and Pyridine Ligands
por: Liu, Zhe, et al.
Publicado: (2014) -
Contrasting Anticancer Activity of Half-Sandwich Iridium(III)
Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands
por: Millett, Adam J., et al.
Publicado: (2015) -
Strategies for conjugating iridium(III) anticancer complexes to targeting peptides via copper-free click chemistry
por: Zhang, Wen-Ying, et al.
Publicado: (2019) -
Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV)
Anticancer Prodrugs
por: Shi, Huayun, et al.
Publicado: (2018) -
NMR studies of group 8 metallodrugs: (187)Os-enriched organo-osmium half-sandwich anticancer complex
por: Needham, Russell J., et al.
Publicado: (2021)